Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. [electronic resource]
Producer: 20051129Description: 4103-11 p. digitalISSN:- 0022-1767
- Animals
- Encephalomyelitis, Autoimmune, Experimental -- drug therapy
- Epitopes, T-Lymphocyte -- pharmacology
- Female
- Gene Expression Regulation -- drug effects
- Immunity, Cellular -- drug effects
- Inflammation -- drug therapy
- Interleukin-13 -- genetics
- Ligands
- Mice
- Mice, Inbred Strains
- Peptide Fragments -- pharmacology
- Proteolipids -- immunology
- Recombinant Proteins
- Retrograde Degeneration -- prevention & control
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.